Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-451-6 | CAS number: 121-17-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: in accordance with guidelines
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- 4-chloro-α,α,α-trifluoro-3-nitrotoluene
- EC Number:
- 204-451-6
- EC Name:
- 4-chloro-α,α,α-trifluoro-3-nitrotoluene
- Cas Number:
- 121-17-5
- Molecular formula:
- C7H3ClF3NO2
- IUPAC Name:
- 1-chloro-2-nitro-4-(trifluoromethyl)benzene
- Details on test material:
- - Name of test material (as cited in study report): Mononitro
- Physical state: pale amber liquid
- Analytical purity: 99%
- Lot/batch No.: IS05-04/03/02
- Expiration date of the lot/batch: n.a. (receipt date 27 May 2003)
- Storage condition of test material: room temperature, in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd, Margate, kent
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 200-350 g
- Housing: groups of five by sex in solid-floor polypropylene cages with stainless steel lids
- Diet : ad libitum (EU rodent diet 5LF2, IPS Ltd, Northants, UK)
- Water : ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2 °C
- Humidity (%): 55 ± 15%
- Air changes (per hr): 15/hour
- Photoperiod (hrs dark / hrs light): 12 hrs continuous light, 12 hrs darkness
IN-LIFE DATES: From: 22 September 2003 To: 09 October 2003
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Details on inhalation exposure:
- The test material was aerosolised using a glass concentric jet nebuliser located at the top of the exposure chamber. the nebuliser was connected to a glass syringe attached to an infusion pump, which provided a continuous supply of test material under pressure, and to a metered compressed air supply.
compressed air was supplied by means of an oil free compressor and passed through a water trap and respiratory quality filters before it was introduced to the nebuliser.
The cylindrical exposure chamber had a volume of approx. 30 litres (dimensions: 28 cm diameter X 50 cm high). the concentration within the exposure chamber was controlled by adjusting the rate of the infusion pump. The extract from the exposure chamber passed through a scrubber trap and was connected with a high efficiency filter to a metered exhaust system. The chamber was maintained under negative pressure.
Prior to the start of the study, test material atmospheres were genearted within the exposure chamber. During thic characterisation period, test material input rates were varied to achieve the required atmospheric concentrations.
the temperature and humidity inside the exposure chamber were measured by an electronic thermometer /humidity meter located in a vacant port in the animals' breathing zone of the chamber and recorded every 30 minutes throughout the 4-hour exposure period.
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: the particle size of the generated atmosphere inside the exposure chamber was determined 3 times during the expsoure period using a marple Personal Cascade impactor. it was as follows:
Mean Achieved Atmosphere Concentreation (mg/L): 5.18
Mean MAss Median Aerodynamic Diameter (µm): 4.00
Inhalable Fraction (% < 4 µm): 50.0
Geometric Standard Deviation: 2.15
CHAMBER FLOW RATE : 70 /h
THEORETICAL CHAMBER EQUILIBRATION TIME: 4 minutes (Silver, 1946) - Duration of exposure:
- ca. 4 h
- Concentrations:
- Mean achieved Atmosphere Concentration : 5.18 mg/L
- No. of animals per sex per dose:
- 10 animals in total (5 males and 5 females)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: individual body weights were recorded prior to treatment on the day of exposure and on Days 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs (hourly intervals during exposure, immediately on removing from the restraining tubes at the end of exposure, 1 hour after termination of exposure and subsequently once daily for 14 days).
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.18 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- Males: 0/5
Females: 0/5
Total: 0/5 - Clinical signs:
- other: Signs of hunched posture and piloerection are commonly seen in animals for short periods on removal from the chamber following 4-hour inhalation studies. Wet fur is commonly recorded.These observations are considered to be associated with the restraint pr
- Body weight:
- One male animal showed a slight body weight loss in week 1 but recovered to show normal development in week 2. Normal development was recorded for all other animals.
- Gross pathology:
- No macroscopic abnormalities were detected at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- No deaths occurred in a group of ten rats exposed to amean achieved atmosphere concentration of 5.18 mg/L for 4 hours. It was therefore considered that the acute inhalation median lethal concentration (4hr LC50) of MONONITRO in the Sprague- dawley Crl:CD (SD) IGS BR strain rat, was greater than 5.18 mg/L.
- Executive summary:
A study was performed to assess the acute inhalation toxicity of the test material, as per OECD Guidelines n. 403.
A group of 10 Sprague-Dawley Crl:CD (SD) IGS BR strain rats (five males and five females) was exposed to an aerosol atmosphere. The animals were exposed for four hours using a nose only exposure system, followed by a 14 day observation period.
The mean achieved atmosphere concentration was 5.18 mg/L, with a standard deviation equal to 0.49.
the characteristics of the achieved atmosphere were as follows:
Mean Achieved Atmosphere Concentreation (mg/L): 5.18
Mean MAss Median Aerodynamic Diameter (µm): 4.00
Inhalable Fraction (% < 4 µm): 50.0
Geometric standard Deviation: 2.15
The mortality data are sumarized as follows: Males: 0/5, Females:0/5, Total: 0/10.
Common abnormalities noted during the study included increased respiratory rate, hunched posture, piloerection and wet fur. there were occasional instances of laboured respiration and noisy respiration and isolated occurrences of lethargy, ataxia and sneezing. Animals recovered steadily to appear normal 2 or 3 days after exposure.
One male animal showed a slight body weight loss in week 1 but recovered to show normal development in week 2. Normal development was recorded for all other animals. No macroscopic abnormalities were detected at necropsy.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.